Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications-Reference-Cited by-同舟云学术

Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications

Published:2020-12-20 Issue:1 Volume:38 Page:1-26
ISSN:0742-0528
Container-title:Chronobiology International
language:en
Short-container-title:Chronobiology International

Author:

Hermida Ramón C.¹²,Smolensky Michael H.²³,Balan Horia⁴,Castriotta Richard J.⁵,Crespo Juan J.¹⁶,Dagan Yaron⁷⁸,El-Toukhy Sherine⁹,Fernández José R.¹,FitzGerald Garret A.¹⁰,Fujimura Akio¹¹¹²,Geng Yong-Jian¹³,Hermida-Ayala Ramón G.¹⁴,Machado Antonio P.¹⁵,Menna-Barreto Luiz¹⁶,Mojón Artemio¹,Otero Alfonso¹⁷,Rudic R. Daniel¹⁸,Schernhammer Eva¹⁹²⁰²¹,Skarke Carsten¹⁰,Steen Tomoko Y.²²,Young Martin E.²³,Zhao Xiaoyun²⁴

Affiliation:

1. Bioengineering & Chronobiology Laboratories; Atlantic Research Center for Information and Communication Technologies (atlanTTic), University of Vigo, Vigo, Spain

2. Department of Biomedical Engineering, Cockrell School of Engineering, the University of Texas at Austin, Austin, Texas, USA

3. Division of Cardiology, McGovern School of Medicine, the University of Texas at Houston, Houston, Texas, USA

4. Department of Internal Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

5. Department of Medicine; Division of Pulmonary, Critical Care and Sleep Medicine; Keck School of Medicine, University of Southern California, Los Angeles, California, USA

6. Centro de Salud de Bembrive, Estructura de Xestión Integrada de Vigo, Servicio Galego de Saúde (SERGAS), Vigo, Spain

7. Applied Chronobiology Research Center, Tel-Hai Academic College, Israel; Human Biology Department, Haifa University, Israel

8. Sleep and Fatigue Institute, Assuta Medical Center, Israel

9. Intramural Research Program, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland, USA

10. Institute for Translational Medicine and Therapeutics, Smilow Center for Translational Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

11. Department of Clinical Pharmacology, Jichi Medical University, Tochigi, Japan

12. Department of Internal Medicine, Shin-Kaminokawa Hospital, Tochigi, Japan

13. Department of Internal Medicine, McGovern School of Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA

14. Chief Pharmacology Officer, Circadian Ambulatory Technology & Diagnostics (CAT&D), Santiago de Compostela, Spain

15. President, Update em Medicina, Lisboa, Portugal

16. Escola de Artes, Ciências e Humanidades, Grupo Multidisciplinar de Desenvolvimento e Ritmos Biológicos (GMDRB), Universidade de São Paulo, São Paulo, Brazil

17. Servicio de Nefrología, Complejo Hospitalario Universitario de Ourense, Estructura de Xestión Integrada de Ourense, Verín e O Barco de Valdeorras, Servicio Galego de Saúde (SERGAS), Ourense, Spain

18. Department of Pharmacology & Toxicology, Augusta University, Augusta, Georgia, USA

19. Department of Epidemiology, Harvard T.H Chan School of Public Health, Boston, Massachusetts, USA

20. Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria

21. Channing Division of Network Medicine, Harvard Medical School, Boston, Massachusetts, USA

22. Department of Microbiology and Immunology, School of Medicine, Georgetown University, Washington, DC, USA

23. Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA

24. Respiratory and Critical Care Medicine Department, Sleep Medicine Center, Tianjin Chest Hospital, Tianjin, China

Publisher

Informa UK Limited

Subject

Physiology (medical),Physiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07420528.2020.1850468

Reference112 articles.

1. Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease

2. Chronobiology of the Hypothalamic-Pituitary-Adrenal and Renin-Angiotensin-Aldosterone Systems

3. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study

4. Cardiovascular Risk of Resistant Hypertension: Dependence on Treatment-Time Regimen of Blood Pressure–Lowering Medications

5. Circadian Pattern of Ambulatory Blood Pressure in Hypertensive Patients With and Without Type 2 Diabetes

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy;Annual Review of Pharmacology and Toxicology;2024-01-23

2. Clinical trial design for assessing hypertension medications: are critical circadian chronopharmacological principles being taking into account?;Expert Review of Clinical Pharmacology;2024-01-12

3. Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings;Journal of Hypertension;2023-11-30

4. Critical appraisal of recent translational chronopharmacology and chronotherapeutic reviews, meta-analyses, and pragmatic patient trials discloses significant deficiencies of design and conduct and suspect findings;Chronobiology International;2023-08-03

5. Cardiovascular research and the arrival of circadian medicine;Chronobiology International;2023-01-02